QUICKLINKS AND VIEW OPITONS
Pravastatin increases new cancers by 25% in the elderly
Tuesday, June 27, 2017 6:06 pm Email this article
There were 25% more new cancers in elderly people 70-82 who were given 40 mg of pravastatin (Pravachol) per day to lower cholesterol compared to those given a placebo according to the PROSPER trial.
Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Meinders AE, Norrie J, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, and Westendorp RG. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet, 2002 Nov 23; 360(9346): 1623-1630.
Author’s Contact Info
University Department of Pathological Biochemistry
University of Glasgow
Scotland, Glasgow, UK
Articles on the same subject can be found here:
Please feel free to share your comments about this article.
© Copyright 2003-2017 - Larry Hobbs - All Rights Reserved.